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Anemia and renal dysfunction:  
Two different conditions but same  
results in cardiovascular disease
We read with interest the article “A prospec-
tive study about impact of renal dysfunction and 
morbidity and mortality on cardiovascular events 
after ischemic stroke” by Penko et al. [1]. They 
aimed at investigating the impact of renal dysfun-
ction on future cardiovascular (CV) events and 
total mortality in patients suffering from ischemic 
stroke. They demonstrated that the patients with 
ischemic stroke and renal dysfunction are at higher 
risk for long-term CV and total mortality. The pa-
tients with ischemic stroke and renal dysfunction 
are also at higher risk for new CV morbidity.
Anemia is an independent nontraditional pre-
dictor of a poor outcome in patients with CV 
diseases as well as in the general population [2]. 
Anemia is common and has been associated with 
hospitalization. It is an independent risk factor for 
mortality in the general population and also in pa-
tients with coronary artery disease, heart failure or 
stroke [3]. In context, if the authors had mentioned 
hemoglobin levels, the results of present study 
would be better.
Renal dysfunction is a crucial parameter for 
predicting CV mortality. Serum creatinine level is 
commonly used for renal function in clinical practi-
ce. However, the glomerular filtration rate (GFR) 
provides more accurate knowledge about renal 
function than the serum creatinine level [4]. GFR 
was estimated using the simplified Modification 
of Diet in Renal Disease (MDRD) formula in the 
current study [5]. The Cockcroft-Gault equation 
(CGE) is another method for calculating the GFR. 
However, the CGE may estimate lower GFR in 
younger age groups compared with the MDRD 
formula, but it can measure higher GFR in older 
individuals compared with the MDRD formula. The 
Chronic Kidney Disease Epidemiology Collabora-
tion (CKD-EPI) recently published an equation for 
GFR using the same variables (serum creatinine 
level, age, sex and race) as the MDRD formula. 
However, the CKD-EPI equation more precisely 
categorized individuals with respect to long-term 
clinical risk of incident end-stage renal disease, all-
-cause mortality, coronary heart disease and stroke 
compared with the MDRD formula [6].
In conclusion, though renal dysfunction is an 
important factor to predict mortality on CV events 
after ischemic stroke, many conditions may be 
associated with it. Therefore, we think that the 
MDRD should be evaluated together with other 
measurement method for GFR in patients with 
ischemic stroke. These findings will enlighten furt-
her studies about renal dysfunction and long-term 
risk of CV events after ischemic stroke.
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